Pricing of Haizheng adamumumab injection in Shaanxi

[January 2, 2020 / medical information list] the new version of the medical insurance catalogue has been implemented, Changfeng pharmaceutical has completed 630 million e rounds of financing, the application for the listing of innovative drug "albutine" is proposed to be included in the priority review, and the first domestic cervical cancer vaccine, Xinkening, is to be listed Daily fresh medicine news, speed reading club and you pay attention to! Since January 1, the national directory of drugs for basic medical insurance, work injury insurance and maternity insurance has been fully implemented throughout the country Several provinces have issued documents which have made it clear that each overall planning area shall not adjust the limited payment scope of drugs in the directory by itself, and shall not make the directory by itself or add drugs in the directory by flexible methods At the same time, 97 newly negotiated drugs have also been officially added to the new version of the national health insurance catalogue and directly linked to the Internet (medical representative) Recently, Guangdong Drug Administration issued the notice on the information of drug spot check and inspection (No 9, 2019), which announced that 11 varieties and 11 batches were unqualified after inspection The unqualified drugs in this sampling inspection mainly include properties, weight differences, loading differences, disintegration time limit, dissolution time limit, dissolution, related substances, content determination, etc (Guangdong Provincial Drug Administration) On March 30, Gansu provincial centralized purchasing network of drugs and medical consumables released the notice on publicity of one vote determination result of "two vote system" for drug purchase and sale (the ninth batch) According to the review, 83 drugs such as letrozole tablets, nilotinib capsules, everolimus tablets, imatinib mesylate tablets were identified as one vote varieties (centralized procurement network of drugs and medical consumables in Gansu Province) Recently, the centralized procurement network of drugs and medical consumables in Gansu Province released the implementation plan for the reform of high value medical consumables in Gansu Province It is required to establish a "blacklist" system for designated medical institutions and medical personnel, and improve the credit evaluation system for designated medical institutions (centralized procurement network of drugs and medical consumables in Gansu Province) Changfeng Pharmaceutical Co., Ltd has successfully completed the e-round financing recently This round of financing is led by Lianxin capital, with the participation of China Resources Zhengda life science fund, Yuanchuang investment, Junxin capital, cornerstone capital, Xiangcheng financial holding, Longma investment and other institutions This financing is used to accelerate the development of respiratory drugs (arterial network) A few days ago, Huatai international acted as its sole sponsor in the delivery of forms to the Hong Kong stock exchange Pioneer pharmaceutical is a clinical stage new drug developer in China, focusing on independent research and development of potential first-class and best-class cancer drugs and other ar related disease drugs (Sina Medical News) Shaanxi provincial centralized procurement network of pharmaceutical equipment issued the announcement on the direct network of adamumumab injection, which pointed out that the adamumumab injection produced by Haizheng and baiaotai enterprises was directly on the network in Shanxi Province, and the price of Haizheng adamumumab injection (0.8ml: 40mg) was 1150 yuan / piece, while baiaotai did not publish the price (centralized procurement network of pharmaceutical equipment of Shaanxi Province) On Tuesday, CDE official website showed that three innovative drugs with obvious therapeutic advantages were proposed to be included in the priority review according to the scope of priority review (1) (medicine cube) On January 1, Suzhou Zejing biopharmaceutical Co., Ltd announced that its donafinil had been successfully used in the phase III clinical study (trial code zgdh3) of first-line treatment of advanced liver cancer (CPHL Pharma online) On December 31, the State Food and Drug Administration approved Xiamen Wantai Canghai Biotechnology Co., Ltd.'s application for listing and registration of bivalent human papillomavirus vaccine (E.coli) (trade name: Xinkening cecolin), the first approved domestic human papillomavirus vaccine suitable for women aged 9-45 (Sina Medical News) On December 31, AstraZeneca's zs-9 powder was approved by the State Food and Drug Administration for marketing to treat adult hyperkalemia (medicine cube) On December 31, Qianyuan pharmaceutical announced that its subsidiary, hynixon pharmaceutical tamsulosin hydrochloride sustained release capsule, had passed the consistency evaluation This is the second manufacturer to pass the consistency evaluation of the drug after Hengrui Tamsulosin hydrochloride sustained-release capsule is a kind of sustained-release capsule, which is mainly used to treat the dysuria caused by adult prostatic hyperplasia (medicine cube) Recently, the State Drug Administration approved the registration application of 13 valent pneumococcal polysaccharide conjugate vaccine declared by Yuxi Watson Biotechnology Co., Ltd The vaccine is mainly used in infants and children aged 6 weeks to 5 years (before the 6th Birthday) to prevent invasive diseases caused by 13 serotypes of pneumococcus, such as type 1 and type 3 (Biovalley) Wuhan health and Health Commission reported on December 31, 2019 that some medical institutions had recently found a number of cases of pneumonia associated with South China Seafood City After expert consultation, it was viral pneumonia So far, no obvious human to human phenomenon has been found in the investigation, and no infection of medical personnel has been found (Wuhan Health Committee)